MNCs

• Recruiting NCT NCT06629324

  Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia

  Not yet reported Vinmec Research Institute of Stem Cell and Gene Technology 58 participants Est. completion 2027-01-31 2 sites
  Other conditions: Autism Spectrum Disorder
  View official trial listing →
• Recruiting NCT NCT06896344

  Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells

  Fondazione IRCCS Policlinico San Matteo di Pavia 10 participants Est. completion 2025-08 1 site
  Other conditions: Primary Myelofibrosis
  View official trial listing →
• Completed NCT NCT00300053

  ACT34-CMI -- Adult Autologous CD34+ Cells

  Not yet reported Lisata Therapeutics, Inc. 321 participants Est. completion 2009-03 26 sites Stand-alone
  Other conditions: Myocardial Ischemia
  View official trial listing →
• Completed NCT NCT00384982

  Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study

  Not yet reported Medical University of Vienna 116 participants Est. completion 2008-08 1 site Stand-alone
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT00824005

  Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)

  Not yet reported The University of Texas Health Science Center, Houston 92 participants Est. completion 2012-05 5 sites Stand-alone
  Other conditions: Chronic Ischemic Heart Disease, Left Ventricular Dysfunction, Angina, Ischemic Cardiomyopathy
  View official trial listing →
• Completed NCT NCT00955669

  Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer

  Not yet reported Third Military Medical University 40 participants Est. completion 2010-08 1 site
  Other conditions: Autologous Transplantation, Diabetic Foot
  View official trial listing →
• Status unknown NCT NCT01143168

  Stem Cell Therapy for Type 1 Diabetes Mellitus

  Not yet reported Cellonis Biotechnology Co. Ltd. 24 participants Est. completion 2011-12 1 site
  Other conditions: Type 1 Diabetes Mellitus
  View official trial listing →
• Status unknown NCT NCT01209611

  Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration

  Not yet reported, Not yet reported Shanghai Jiao Tong University School of Medicine 30 participants Est. completion 2014-12 1 site Stand-alone
  Other conditions: Tissue Expansion;, Skin Regeneration;, Reconstruction;, Bone Marrow Mononuclear Cells
  View official trial listing →
• Completed NCT NCT01333982

  Neonatal Sepsis, Evaluation, Bangladesh

  Not yet reported International Centre for Diarrhoeal Disease Research, Bangladesh 20000 participants Est. completion 2013-12 1 site Stand-alone
  Other conditions: Sepsis
  View official trial listing →
• Completed NCT NCT01343511

  Safety and Efficacy of Stem Cell Therapy in Patients With Autism

  Not yet reported, Not yet reported Shenzhen Beike Bio-Technology Co., Ltd. 37 participants Est. completion 2011-05 1 site Stand-alone
  Other conditions: Autism
  View official trial listing →
• Status unknown NCT NCT01832441

  Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus.

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2016-09 1 site
  Other conditions: Diabetes Mellitus.
  View official trial listing →
• Status unknown NCT NCT01832454

  Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2015-12 1 site
  Other conditions: Cerebral Palsy
  View official trial listing →
• Status unknown NCT NCT01833975

  Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 50 participants Est. completion 2016-09 1 site
  Other conditions: Spinal Cord Injury.
  View official trial listing →
• Status unknown NCT NCT01834040

  Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 30 participants Est. completion 2016-10 1 site
  Other conditions: Muscular Dystrophy, Duchenne Muscular Dystrophy
  View official trial listing →
• Status unknown NCT NCT01834053

  Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 50 participants Est. completion 2016-06 1 site
  Other conditions: Huntington Disease
  View official trial listing →
• Status unknown NCT NCT01834066

  Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 25 participants Est. completion 2016-12 1 site
  Other conditions: Muscular Dystrophy, Duchenne Muscular Dystrophy,
  View official trial listing →
• Status unknown NCT NCT01834079

  Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 24 participants Est. completion 2016-07 1 site
  Other conditions: Optic Atrophy
  View official trial listing →
• Status unknown NCT NCT01834664

  Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2016-06 1 site
  Other conditions: Ataxic Infantile Cerebral Palsy
  View official trial listing →
• Status unknown NCT NCT01836562

  A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 100 participants Est. completion 2016-06 1 site
  Other conditions: Autism
  View official trial listing →
• Status unknown NCT NCT01883661

  Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

  Not yet reported, Not yet reported Chaitanya Hospital, Pune 15 participants Est. completion 2016-12 1 site
  Other conditions: Multiple Sclerosis
  View official trial listing →
• Completed NCT NCT02253160

  An Evaluation of the Spectra Optia CMNC Collection Procedure

  Not yet reported Terumo BCT 23 participants Est. completion 2015-01 2 sites
  Other conditions: Healthy Apheresis Donors, Mononuclear (MNC) Cell Donors
  View official trial listing →
• Completed NCT NCT02280135

  Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

  Not yet reported Red de Terapia Celular 8 participants Est. completion 2017-03 1 site Stand-alone
  Obstructive sleep apnea
  View official trial listing →
• Terminated NCT NCT02323477

  Human Umbilical Cord Stroma MSC in Myocardial Infarction

  Not yet reported, Not yet reported Ankara University 46 participants Est. completion 2018-12-30 1 site
  Other conditions: Chronic Ischemic Cardiomyopathy, Coronary Artery Bypass Surgery
  View official trial listing →
• Completed NCT NCT02387749

  Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .

  Not yet reported Cairo University 10 participants Est. completion 2016-12 Stand-alone
  Other conditions: Diabetic Peripheral Neuropathy
  View official trial listing →
• Completed NCT NCT02490163

  Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC)

  Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 51 participants Est. completion 2016-01 1 site Stand-alone
  Other conditions: GvHD, Lung Graft Dysfunction
  View official trial listing →
• Completed NCT NCT02533895

  Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood

  Not yet reported Activartis Biotech 67 participants Est. completion 2015-10 2 sites Stand-alone
  Other conditions: Childhood Solid Tumor
  View official trial listing →
• Status unknown NCT NCT02587806

  A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

  Not yet reported, Not yet reported Novo Cellular Medicine Institute LLP 69 participants Est. completion 2017-02 2 sites Stand-alone
  Other conditions: Multiple Sclerosis, Relapsing-Remitting
  View official trial listing →
• Status unknown NCT NCT02648516

  Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

  Not yet reported, Not yet reported Beijing 302 Hospital 20 participants Est. completion 2022-12 1 site Stand-alone
  Other conditions: Human Immunodeficiency Virus, Disorder of Immune Reconstitution
  View official trial listing →
• Completed NCT NCT02651376

  Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

  Not yet reported, Not yet reported Beijing 302 Hospital 20 participants Est. completion 2017-08 Stand-alone
  Other conditions: Human Immunodeficiency Virus, Immunodeficiency
  View official trial listing →
• Completed NCT NCT02662400

  Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies

  Not yet reported, Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 7 participants Est. completion 2016-12 Stand-alone
  Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
  View official trial listing →
• Terminated NCT NCT03111238

  The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

  Not yet reported Ixaka Ltd 3 participants Est. completion 2021-03-31 15 sites Stand-alone
  Type 2 diabetesCardiovascular disease Other conditions: Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM), Diabetes Mellitus, Type 1, Critical Limb Ischemia (CLI)
  View official trial listing →
• Terminated NCT NCT03174522

  The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

  Not yet reported Ixaka Ltd 49 participants Est. completion 2023-02-13 15 sites Stand-alone
  Type 2 diabetesCardiovascular disease Other conditions: Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM), Diabetes Mellitus, Type 1, Critical Limb Ischemia (CLI)
  View official trial listing →
• Active, not recruiting NCT NCT03880656

  BM-MNCs for Lower Extremity Compartment Syndrome Injury

  Not yet reported Oregon Health and Science University 18 participants Est. completion 2026-06 1 site Stand-alone
  Other conditions: Compartment Syndrome Traumatic Lower Extremity
  View official trial listing →
• Status unknown NCT NCT03943940

  BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients

  Not yet reported, Not yet reported Van Hanh General Hospital 60 participants Est. completion 2020-08-30 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT04255004

  Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia

  Not yet reported Ospedale San Donato 76 participants Est. completion 2019-12
  Other conditions: Critical Limb Ischemia, Diabetic Foot
  View official trial listing →
• Status unknown NCT NCT04501341

  BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients

  Not yet reported, Not yet reported Indonesia University 15 participants Est. completion 2021-12-01 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT04882683

  Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

  Not yet reported Shandong Qilu Stem Cells Engineering Co., Ltd. 50 participants Est. completion 2022-12-31 1 site Stand-alone
  Other conditions: Ulcerative Colitis
  View official trial listing →
• Active, not recruiting NCT NCT04898543

  QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors

  Not yet reported ImmunityBio, Inc. 50 participants Est. completion 2026-05-31 2 sites Stand-alone
  Other conditions: Metastatic Solid Tumor
  View official trial listing →
• Completed NCT NCT04975698

  HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

  Not yet reported Catherine Bollard 12 participants Est. completion 2026-01-05 11 sites
  Other conditions: HIV Associated Lymphoma
  View official trial listing →
• Status unknown NCT NCT04997590

  Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing

  Not yet reported Qianfoshan Hospital 40 participants Est. completion 2022-12-10 1 site Stand-alone
  Other conditions: Bone Nonunion
  View official trial listing →
• Completed NCT NCT05000593

  Clinical Study of Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Knee Osteoarthritis

  Not yet reported Lili Cao 30 participants Est. completion 2022-09-01 1 site Stand-alone
  Osteoarthritis
  View official trial listing →
• Completed NCT NCT05134168

  LIFT With or Without Injection of BM-MNCs

  Not yet reported Mansoura University 70 participants Est. completion 2021-11-01 1 site
  Other conditions: Anal Fistula
  View official trial listing →
• Completed NCT NCT05193877

  Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

  Not yet reported Global Stem Cell Center, Baghdad 60 participants Est. completion 2024-01-16 1 site
  Other conditions: Treatment Complication
  View official trial listing →
• Completed NCT NCT05307536

  Autologous BMMNCs Combined With Educational Intervention for ASD

  Not yet reported Vinmec Research Institute of Stem Cell and Gene Technology 54 participants Est. completion 2023-12-30 1 site Stand-alone
  Other conditions: Autism Spectrum Disorder
  View official trial listing →
• Status unknown NCT NCT05628272

  MNCs for Bone Marrow Failure After Malignant Diseases Children Chemotherapy

  Not yet reported Qianfoshan Hospital 20 participants Est. completion 2024-09-01 1 site
  Other conditions: Cord
  View official trial listing →
• Status unknown NCT NCT05999656

  Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot

  Not yet reported The First Affiliated Hospital with Nanjing Medical University 24 participants Est. completion 2024-11-28 1 site Stand-alone
  Other conditions: Refractory Diabetic Foot, Human Cord Blood-derived Mononuclear Cells, Efficacy, Safety, Local Injection
  View official trial listing →
• Status unknown NCT NCT06427642

  Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

  Not yet reported Shandong Qilu Stem Cells Engineering Co., Ltd. 120 participants Est. completion 2025-04-30 1 site Stand-alone
  Other conditions: Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia, Short Bowel Syndrome
  View official trial listing →
• Not yet recruiting NCT NCT06729320

  A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

  Not yet reported Beijing GoBroad Hospital 40 participants Est. completion 2025-12-01 1 site Stand-alone
  Other conditions: Refractory Immune Effector Cell-related Hemocytopenia
  View official trial listing →
• Not yet recruiting NCT NCT07175207

  Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis

  Not yet reported Zhejiang Cancer Hospital 10 participants Est. completion 2026-12-31 1 site Stand-alone
  Other conditions: Chronic Radiation Induced Intestinal Injury, Chronic Radiation Enteritis
  View official trial listing →
• Not yet recruiting NCT NCT07177456

  Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury

  Not yet reported Zhejiang Cancer Hospital 10 participants Est. completion 2026-12-31 Stand-alone
  Other conditions: Radiation-induced Lung Injury
  View official trial listing →
• Not yet recruiting NCT NCT07698080

  Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

  Not yet reported Hematology department of the 920th hospital 60 participants Est. completion 2028-07-03 Stand-alone
  Other conditions: Leukemia, Lymphoma, Thalassemia, Aplastic Anemia, Myelodysplastic Syndromes
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT02662400

No related coverage yet.